Cardiac safety is the #1 reason for drug development failure & post-market recalls.
High-quality data and reporting are essential to drive decisions in both site-based and DCTs from Phase 1 to Phase IV. As the most trusted name in cardiac safety with 50 years of experience, Clario centralizes the approach to data collection with rigorous, responsive and reliable tools that deliver credible, compliant, high-quality data you can be certain of.
Our goal is always to:
- Improve patient safety and enrollment
- Increase data access leading to reduced timelines
- Deliver scientific-grade data to reduce variability
- Solutions with the patients in mind
Regardless of therapeutic area or where your data is coming from, Clario helps you collect reliable evidence with certainty—in site-based and DCT environments— enabling you to bring new drugs and therapies to market. Learn how our solutions and scientific experts can help you effectively pitch, expertly design and efficiently implement successful cardiac safety data for your submission.
Collect continuous ECG data with certainty in site-based or decentralized clinical trials with our flexible technology solutions and patient-friendly devices.
Blood Pressure Services
Collect and centrally analyze accurate, consistent, quality blood pressure data from site-based to decentralized trials.
ECG — On-site to DCT and Phase I-IV
Monitor every heartbeat with precision from anywhere to ensure safety throughout your site-based or decentralized clinical trial.
Phase I/TQT Cardiac Assessment
Fulfill your ICH E14 requirement early, minimize risk and potentially reduce costs throughout your trial by collaborating with our Phase 1 Center of Excellence.
Regulatory Consultation and Statistical Analysis Expertise
Leverage our industry key opinion leaders to understand the complex regulatory landscape while minimizing risk with confidence.
Clario advances your decentralized clinical trial with the extensible power of certainty
With Clario-operated logistics hubs in the US, EU and Japan with the largest, most diverse inventory of validated equipment and 136,000 devices shipped per year.
Clinical and scientific expertise
50 years of clinical trial experience in cardiac safety plus a team of cardiologists who bring more than 200 years of clinical expertise powers certainty.
The broadest endpoint technology platform
Our flexible equipment and overread services ensure consistent, quality data, so you can be certain you’re collecting credible data.
We help power trial continuity patient reminders, coaching and demonstrations to ensure patients experience success.
Proven results earn trust
new drug approvals
years of science
combined years of clinical experience
approvals from TQTS alone
Cardiac Safety Science Team
Todd Rudo, M.D
Chief Medical Officer
Borje Darpo, M.D., Ph.D.
Chief Scientific Officer, Cardiac Safety
Robert Kleiman, M.D.
Chief Science and Regulatory Advisor, Cardiology
Joel Morganroth, M.D.
Chief Scientific Advisor, Cardiac Safety
Onglee Weng, M.D.
Vice President, General Manager, Clario-Shanghai and Cardiology
Jean T. Barbey, M.D.
Expert Cardiac Safety Medical Advisor
Jeff Heilbraun, M.S.
Vice President, Medical and Scientific Affairs, Cardiology
Luc Dekie, Ph.D.
Director Scientific Affairs, Cardiology
Vickas Patel, M.D., Ph.D.
Vice President and Chief Medical Officer, Cardiology
Increase confidence in site performance with Clario Certified Sites.
Clario Certified Sites have completed our Certified Site program to ensure that each study is conducted in an optimal manner and results in the highest quality data. The certification program requires each site to go through an extensive training and testing process. These sites help sponsors reduce study start-up time with well-trained and well-equipped sites.
Learn more or speak with one of our experts
Our team of clinical trial cardiac safety experts are always available to address questions about our cardiac safety solutions. Submit your contact information and we’ll be in touch shortly.